BackExcelsior Biopharma Overview

Excelsior Biopharma Total Liabilities

Track Excelsior Biopharma's total liabilities ($760M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$763.08M
↑ 47.79% YoYΔ $246.74M vs prior year quarter

Peer trimmed avg / median

Loading

Excelsior Biopharma Total Liabilities History

Loading

Excelsior Biopharma vs. peers: Total Liabilities Comparison

Loading

Excelsior Biopharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Excelsior Biopharma (6496.TWO) FAQ

Excelsior Biopharma's total liabilities stands at $760M as of September 2026. That compares with $520M in the prior-year period — up 47.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Excelsior Biopharma reported $760M in total liabilities versus $520M a year earlier — a 47.8% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $520M in the prior-year period — up 47.8% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Excelsior Biopharma's total liabilities evolved across reporting periods, while the comparison chart places 6496.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.